Budczies J; Denkert C; Győrffy, Balázs; Schirmacher P; Stenzinger A
(2017)
BACKGROUND: Inhibition of the PD-L1/PD-1 immune checkpoint axis represents one of the most promising approaches of immunotherapy for various cancer types. However, immune checkpoint inhibition is successful only in ...